Denmark
Reshape Biotech, headquartered in Denmark, is a transformative force in the biotech sector, founded in 2018. The company is reshaping laboratory processes through cutting-edge AI and Automation, aiming to reinvent an industry with over a century of legacy. By enabling biotech companies to increase their experimental throughput by more than 500 times, Reshape Biotech positions itself as critical infrastructure for sectors addressing global challenges like alternative protein development and sustainable agriculture.
The startup boasts a multidisciplinary team composed of experts ranging from biology PhDs to skilled hardware and software engineers. This diversity is pivotal for their mission to standardize how biotech research is conducted globally, allowing researchers to collaborate on a large scale.
Attracting significant attention from investors, their latest $20.00M Series A funding in April 2024 saw participation from prominent supporters like Y Combinator, ACME Capital, and Astanor Ventures. With high-profile backers, Reshape Biotech is set to define the future of lab automation.
